report findings and recommendations regarding human subjects protection and genetic testing over and beyond whatever findings and recommendations it provides within the next few weeks with respect to cloning.

NBAC's operating priorities for this year changed abruptly in the wake of the press announcements on February 23, 1997, that scientists in Scotland had cloned a lamb from a single cell from the mammary tissue of a 6-year-old ewe. The scientists' research report appeared in that week's edition of the scientific journal Nature. On February 24, President Clinton sent a letter to NBAC Chairman Shapiro, requesting that the National Bioethics Advisory Commission undertake a thorough review of the legal and ethical issues associated with the use of this technology—namely, cloning—and report back to him within 90 days with recommendations on possible Federal actions to prevent its abuse.

Further, on March 4, President Clinton issued to the heads of executive departments and agencies a memorandum entitled, “Prohibition on Federal Funding for Cloning of Human Beings.” In that memorandum he mentioned his assignment to NBAC, noting that cloning technology offers the potential for enormous scientific breakthroughs that could offer benefits in such areas as medicine and agricultural while raising profound ethical issues, particularly with respect to its possible use to clone humans.

Since February 25, NBAC has devoted an extraordinary effort toward fulfilling President Clinton's request. The commissioners quickly developed a preliminary framework for the issues they wished to address and organized themselves into several informal working groups so that they initially could pursue various subsets of these issues in parallel. Then they identified within each issue area the specific topics for which they desired additional information, and they provided guidance to ÑBAC staff regarding leading experts in relevant scientific or professional disciplines who might be sources of or at least links to sources of such information.

Using this guidance, NBAC staff contracted for a series of special analyses on a variety of topics including the state of the science related to cloning, the current array of State and local level statutes that might affect cloning and/or cloning related research, and the historical experience with moratoria associated with other areas where rapid scientific advances raised major ethical issues—that is, fetal research, gene therapy, and recombinant DNA research.

Further, NBAC staff invited experts in science, religion, ethics and other relevant subject matter areas to address the commission directly and participate in indepth discussions of critical issues. Moreover, NBAC staff made special efforts to accommodate within each meeting agenda those members of the public who requested an opportunity to address the commission. To date the full NBAC has held three meetings largely or wholly devoted to the cloning assignment.

Between meetings, the informal subgroups have pursued their respective assignments through special meetings, conference calls or e-mail exchanges, and the NBAC staff has maintained regular, often daily contact with Chairman Shapiro and the other commissioners in anticipation of their needs for assistance or in response to specific requests. The commissioners are optimistic that they can

produce a thorough, well reasoned report to President Clinton on or about the end of this month.

The NBAC charter assigns to the Department of Health and Human Services the responsibility for providing management and administrative support services for NBAC. Secretary Shalala initially delegated this responsibility to the Director, National Institutes of Health, who redelegated it to the Director, Office for the Protection from Research Risks. The Director, OPRR established the NBAC office, recruited the initial complement of staff, and participated with them and Chairman Shapiro in planning and implementation of the initial NBAC activities.

During the fall 1996, the Director, NIH expressed concern that the organizational placement of the NBAC office could create the appearance of conflict of interest. That is, because NBAC inevitably will focus on many issues that fall within the purview of the OPRR, any NBAC assessments that relate to OPRR's activities, whether favorable or otherwise, might lack credibility in the eyes of some observers. After weighing these concerns, Secretary Shalala, on November 1, 1996, reassigned responsibility for NBAC management and administrative support to the Assistant Secretary for Health, who in turn requested that I provide day to day oversight of the NBAC staff in my capacity as his science advisor.

Subsequently, I also assumed the role of acting executive director, pending the recruitment of an appropriately qualified individual to fill this position on a regular basis. And I arranged for a DHHS staff member thoroughly experienced in working with advisory commissions to serve as Acting Deputy Director. The Department recently published the vacancy announcement for the position of NBAC executive director. The position is classified within the senior executive service, and, depending upon the qualifications of the individual selected, offers an annual salary in the range of $104,000 to $120,000 and possibility higher if the individual selected is a physician.

We expect significant competition for this vacancy and look forward to receipt of applications by the deadline, June 4, 1997. The NBAC staff currently consists of eight full-time and four part-time individuals. As NBAC activities continue to evolve, future staffing needs will be assessed by the executive director in consultation with Chairman Shapiro and in context of available resources.

The budget for NBAC this year is approximately $1.6 million. Almost half of those funds-$760,000-are being provided by agencies of the U.S. public health service, namely the NIH, the CDC, the FDA and the Agency for Health Care Policy and Research. The remainder of the funds-$850,000—are being provided by six other departments or agencies, namely the Department of Defense, the Department of Veterans Affairs, the Department of Energy, the Department of Agriculture, the National Aeronautics and Space Administration, and the National Science Foundation. The Office of Science and Technology Policy within the executive office of the President was instrumental in facilitating the arrangements for joint funding of NBAC.

Mr. Chairman, I know that I speak for my colleagues as well as

myself in saying that we are eager to facilitate the work of NBAC as best we can, and that we feel privileged to work with this capable and dedicated group of commissioners. If you have questions I will be pleased to respond either now or for the record.

[The prepared statement of Mr. Raub follows:]

1

Good morning, Mr. Chairman. My name is William F. Raub. I am the Deputy Assistant Secretary for Science Policy within the Office of the Assistant Secretary for Planning and Evaluation, Department of Health and Human Services. I also am serving as the Acting

Executive Director of the National Bioethics Advisory Commission (NBAC), pending

completion of recruitment for that position. I appreciate this opportunity to present background information on NBAC and to describe its current activities.

Establishment of NBAC

President Clinton established NBAC by Executive Order dated October 3, 1995. The

Order describes the functions as follows:

"(a) NBAC shall provide advice and make recommendations to the National Science and Technology Council and to other appropriate government entities regarding the following

matters:

(1) the appropriateness of departmental, agency, or other governmental programs, policies, assignments, missions, guidelines, and regulations as they relate to bioethical issues arising from research on human biology and behavior; and

(2) applications, including the clinical applications, of that research.

(b) NBAC shall identify broad principles to govern the ethical conduct of research, citing

specific projects only as illustrations for such principles.

c) NBAC shall not be responsible for the review and approval of specific projects.

(d) In addition to responding to requests for advice and recommendations from the National Science and Technology Council, NBAC also may accept suggestions of issues for consideration from both the Congress and the public. NBAC also may identify other bioethical issues for the

2

purpose of providing advice and recommendations, subject to the approval of the National

Science and Technology Council."

The Order also indicates that NBAC will terminate on October 3, 1997 unless extended prior to that date.

The Assistant to the President for Science and Technology issued the Charter for NBAC

in July, 1996. In describing the functions of s the following:

"As a first priority, the Commission will direct its attention to consideration of:

A.

Protection of the rights and welfare of human research subjects; and

B.

Issues in the management and use of genetic information including but not limited

to human gene patenting."

Also in July, 1996, the President appointed the members of NBAC. The Chairman is Harold T.

Shapiro, Ph.D., President of Princeton University.

Initial Activities of NBAC

NBAC held its first meeting on October 4, 1996. Following a series of background presentations -- including remarks by the Assistant to the President for Science and Technology, other Executive Branch staff, a legislative assistant to former Senator Hatfield and the minority staff director of the Senate Committee on Governmental Affairs -- and a general discussion of the President's charge to NBAC, Chairman Shapiro elected to create two subcommittees. The Human Subjects Subcommittee, chaired by James Childress, Ph.D. of the University of Virginia, has responsibility for examining the current system of protections for human research subjects -with emphasis on determining whether research sponsors and performers are adhering to the socalled "Common Rule" (i.e., a set of essentially identical regulations issued simultaneously by 16